p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations

被引:8
作者
Lao, Xianjun [1 ]
Chen, Zhiping [2 ]
Qin, Aiping [3 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning 530021, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Res Ctr Reprod Med, Dept Obstet & Gynecol, Nanning 530021, Guangxi Zhuang, Peoples R China
关键词
p53 Arg72Pro polymorphism; Endometriosis; Meta-analysis; CODON; 72; POLYMORPHISM; HARDY-WEINBERG EQUILIBRIUM; TP53; GENE; GENOTYPING ERRORS; ASSOCIATION; CANCER; METAANALYSIS; INFERTILITY; VARIANTS; WOMEN;
D O I
10.1007/s00404-015-3923-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Findings from studies on the association between the p53 Arg72Pro polymorphism and endometriosis susceptibility have so far been inconsistent. Therefore, we undertook a meta-analysis to clarify the association of p53 Arg72Pro polymorphism with the risk of endometriosis. Relevant studies were chosen by searching PubMed, Embase, the Cochrane Library databases, CNKI, Wanfang database, and CBM for articles published before and up to April 30, 2015. Two independent reviewers performed the eligibility evaluation and data extraction. The odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated for the overall risk estimate. Eleven case-control studies involving 1834 endometriosis cases and 2331 controls were included. Pooled data analysis suggested that the p53 72Pro variant is a significant endometriosis risk factors in comparison to the 72Arg variant (Pro vs. Arg: OR = 1.298, 95 % CI 1.082-1.558; Pro/Pro vs. Arg/Arg: OR = 1.751, 95 % CI 1.130-2.711; Pro/Arg vs. Arg/Arg: OR = 1.530, 95 % CI 1.174-1.994), which was strengthened in the dominant model (Pro/Pro + Arg/Pro vs. Arg/Arg: OR = 1.570, 95 % CI = 1.181-2.087). In the stratified analysis by ethnicity and Hardy-Weinberg equilibrium (HWE) in the controls, we found strong associations in Asians and in studies that were consistent with HWE. However, the analyses of the revised American Fertility Society (rAFS) stage and the menopausal status subgroup did not reveal any significant associations. In conclusion, the p53 Arg72Pro polymorphism was closely related to the risk of endometriosis, especially in Asian populations.
引用
收藏
页码:1023 / 1031
页数:9
相关论文
共 41 条
[1]   P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women [J].
Agorastos, T ;
Masouridou, S ;
Lambropoulos, AF ;
Chrisafi, S ;
Miliaras, D ;
Pantazis, K ;
Constantinides, TC ;
Kotsis, A ;
Bontis, I .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (04) :277-280
[2]   Association of p53 codon 72 polymorphism with endometriosis [J].
Ammendola, Maria ;
Gloria-Bottini, Fulvia ;
Sesti, Francesco ;
Piccione, Emilio ;
Bottini, Egidio .
FERTILITY AND STERILITY, 2008, 90 (02) :406-408
[3]   Analysis of codon 72 polymorphism of the TP53 gene in infertile women with and without endometriosis [J].
Bianco, Bianca ;
Christofolini, Denise Maria ;
Brandes, Ariel ;
Lerner, Tatiana Goberstein ;
Goncalves-Filho, Rubens Paulo ;
Bentes de Souza, Angela Mara ;
Barbosa, Caio Parente .
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2011, 33 (01) :37-42
[4]   p53 at a glance [J].
Brady, Colleen A. ;
Attardi, Laura D. .
JOURNAL OF CELL SCIENCE, 2010, 123 (15) :2527-2532
[5]  
Brosens I, 2011, INDIAN J MED RES, V133, P581
[6]   Schizophrenia and breast cancer incidence A systematic review of clinical studies [J].
Bushe, Chris J. ;
Bradley, Andrew J. ;
Wildgust, Hiram J. ;
Hodgson, Richard E. .
SCHIZOPHRENIA RESEARCH, 2009, 114 (1-3) :6-16
[7]   The proline form of p53 codon 72 polymorphism is associated with endometriosis [J].
Chang, CC ;
Hsieh, YY ;
Tsai, FJ ;
Tsai, CH ;
Tsai, HD ;
Lin, CC .
FERTILITY AND STERILITY, 2002, 77 (01) :43-45
[8]  
Dastjerdi MN, 2013, IRAN J REPROD MED, V11, P473
[9]   Endometriosis and infertility: pathophysiology and management [J].
de Ziegler, Dominique ;
Borghese, Bruno ;
Chapron, Charles .
LANCET, 2010, 376 (9742) :730-738
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188